Parathyroid Disease Treatment Global Market Report 2025
상품코드:1810992
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 부갑상선 질환 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 연평균 복합 성장률(CAGR) 7.0%로 확대되어 31억 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 고령화 인구 증가, 비외과적 치료의 이용 확대, 폐경 후 골 장애의 이환율 상승, 희귀질환 관리를 대상으로 한 정부의 이니셔티브, 저침습 부갑상선 적출술의 광범위한 채용 등과 관련이 있습니다. 이 기간 동안 예상되는 주요 동향에는 개별화 호르몬 요법으로의 전환, 장시간 작용 호르몬 유사체의 개발, 내분비 진단에 AI 도입, 칼슘 감수성 수용체를 표적으로하는 약물에 대한 주목, 부갑상선 호르몬 유사체의 발전 등이 있습니다.
만성 신장병(CKD) 유병률 증가는 부갑상선 질환 치료 시장의 성장을 이끌 것으로 예측됩니다. CKD는 신장 기능이 시간이 지남에 따라 감소하고 칼슘과 인과 같은 미네랄 불균형을 일으키는 진행성 질환입니다. 이 CKD 사례 증가는 당뇨병의 이환율 증가로 인한 것이 큽니다. 고혈당 상태가 오래 지속되면 신장의 여과 장치가 손상되어 당뇨병성 신장증으로 이어질 수 있기 때문입니다. 부갑상선 질환의 치료는 CKD 관리, 특히 진행된 CKD에서 흔히 발견되는 합병증으로 미네랄 균형을 깨고 골 장애를 일으키고 혈관 석회화를 일으키는 이차성 부갑상선 기능 항진증을 치료하는 데 매우 중요합니다. 예를 들어 2024년 6월 호주 보건복지실은 CKD 사망률이 2021년 4.2%, 2022년 6.2% 증가했다고 보고했습니다. 2022년 CKD에 의한 사망자 수는 약 2만 2,000명으로 호주 전체 사망자 수의 11%를 차지했으며, 사망률은 인구 10만명당 84명이었습니다. 따라서 CKD의 유병률 증가는 부갑상선 질환 치료 시장에 박차를 가하고 있습니다.
부갑상선 질환 치료 시장의 기업은 부갑상선 기능 저하증 환자의 칼슘 조절을 개선하고 투여 횟수를 줄이는 부갑상선 호르몬 프로드러그를 개발함으로써 호르몬 보충 요법을 진행하고 있습니다. 부갑상선 호르몬(PTH) 프로드러그는 신체에서 활성화되어 칼슘과 인산의 균형을 유지하는 데 도움이 되는 불활성 화합물입니다. 예를 들어, 2024년 8월, 덴마크에 본사를 둔 바이오 의약품 회사 Ascendis Pharma A/S는 성인의 만성 부갑상선 기능 저하증 치료를 위한 PTH 프로드러그인 YORVIPATH(Palopegteriparatide)의 FDA 승인을 받았습니다. 이 1일 1회 투여의 치료는 24시간 지속적으로 호르몬을 투여함으로써, 호르몬 결핍증을 직접 대처하고, 기존 칼슘이나 비타민 D 보충제를 대신하는 치료를 기재하고 있습니다. YORVIPATH의 승인은 부갑상선 기능 장애 환자의 치료 충고와 임상 결과를 개선하기 위해 혁신적인 호르몬 보충 요법에 대한 관심이 높아지고 있음을 강조합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 부갑상선 질환 치료 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 부갑상선 질환 치료 시장 : 성장률 분석
세계의 부갑상선 질환 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 부갑상선 질환 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 부갑상선 질환 치료 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 부갑상선 질환 치료 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
칼슘 채널 차단제
비스포스포네이트
프리카마이신
호르몬 보충 요법
기타
세계의 부갑상선 질환 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
경구
비경구
세계의 부갑상선 질환 치료 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
온라인 약국
소매 약국
세계의 부갑상선 질환 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
재택치료
전문센터
기타
세계의 부갑상선 질환 치료 시장 : 칼슘 채널 차단제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
시나칼셋
에테르칼세티드
세계의 부갑상선 질환 치료 시장 : 비스포스포네이트별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
알렌드로네이트
이반도로네이트
리세드로네이트
졸레드론산
세계의 부갑상선 질환 치료 시장 : 프리카마이신별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
미트라마이신(프리카마이신) 단제요법
프리카마이신을 포함한 병용 요법
세계의 부갑상선 질환 치료 시장 : 호르몬 보충 요법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
에스트로겐 요법
프로게스테론 요법
복합호르몬요법
선택적 에스트로겐 수용체 조절제(SERM)
세계의 부갑상선 질환 치료 시장 : 기타 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
부갑상선 호르몬(PTH) 유사체
수술(부갑상선 적출술)
영양보조식품
라이프 스타일 및 영양 개입
제7장 지역별/국가별 분석
세계의 부갑상선 질환 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 부갑상선 질환 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
부갑상선 질환 치료 시장 :경쟁 구도
부갑상선 질환 치료 시장 : 기업 프로파일
AstraZeneca PLC
Amgen Inc.
Teijin Pharma Limited
Kyowa Kirin Co. Ltd.
Shandong Buchang Pharmaceuticals Co. Ltd.
제31장 기타 주요 기업 및 혁신 기업
OPKO Health Inc.
Septerna Inc.
Entera Bio Ltd.
Visen Pharmaceuticals(Shanghai) Co. Ltd.
Ascendis Pharma A/S
Aeterna Zentaris Inc.
MBX Biosciences Inc.
STERIS Healthcare Private Limited
Crinetics Pharmaceuticals Inc.
Amorphical Ltd.
Vidasym Inc.
Extend Biosciences Inc.
Rani Therapeutics LLC
Pathalys Pharma Inc.
ProLynx LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
부갑상선 질환 치료 시장(2029년) : 새로운 기회를 제공하는 국가
부갑상선 질환 치료 시장(2029년) : 새로운 기회를 제공하는 부문
부갑상선 질환 치료 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Parathyroid disease treatment involves medical and surgical methods aimed at managing disorders of the parathyroid glands, small endocrine glands in the neck responsible for regulating calcium and phosphorus levels in the body by secreting parathyroid hormone (PTH).
The primary treatment options for parathyroid disease include calcimimetics, bisphosphonates, plicamycin, hormone replacement therapy, and other therapies. Calcimimetics are medications that lower parathyroid hormone (PTH) levels by mimicking calcium and stimulating calcium-sensing receptors on the parathyroid glands. These drugs can be administered orally or parenterally and are distributed through hospital pharmacies, online pharmacies, and retail pharmacies. They are utilized by a range of end-users, including hospitals, homecare settings, specialty centers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The parathyroid disease treatment market research report is one of a series of new reports from The Business Research Company that provides parathyroid disease treatment market statistics, including the parathyroid disease treatment industry global market size, regional shares, competitors with the parathyroid disease treatment market share, detailed parathyroid disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the parathyroid disease treatment industry. These parathyroid disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The parathyroid disease treatment market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the rising prevalence of chronic kidney disease, increasing cases of osteoporosis, heightened awareness of endocrine disorders, expansion of diagnostic capabilities, and improved access to specialty healthcare.
The parathyroid disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The projected growth in the forecast period can be linked to the increasing aging population, greater use of non-surgical treatments, a rising incidence of postmenopausal bone disorders, government initiatives targeting rare disease management, and wider adoption of minimally invasive parathyroidectomy. Key trends expected during this time include a move toward personalized hormone therapies, development of long-acting hormone analogs, incorporation of AI in endocrine diagnostics, focus on drugs targeting calcium-sensing receptors, and advancements in parathyroid hormone analogs.
The increasing prevalence of chronic kidney disease (CKD) is expected to drive growth in the parathyroid disease treatment market. CKD is a progressive condition where kidney function declines over time, causing mineral imbalances like calcium and phosphorus. This rise in CKD cases is largely attributed to the growing incidence of diabetes, as prolonged high blood sugar levels can damage the kidneys' filtering units, leading to diabetic nephropathy. Treating parathyroid disease is crucial for managing CKD, particularly to address secondary hyperparathyroidism, a common complication in advanced CKD that disrupts mineral balance, contributes to bone disorders, and causes vascular calcification. For example, in June 2024, the Australian Institute of Health and Welfare reported that CKD mortality rates increased by 4.2% in 2021 and 6.2% in 2022. In 2022, CKD was responsible for approximately 22,000 deaths, accounting for 11% of all deaths in Australia, with a mortality rate of 84 per 100,000 people. Hence, the growing prevalence of CKD is fueling the parathyroid disease treatment market.
Companies in the parathyroid disease treatment market are advancing hormone replacement therapies by developing parathyroid hormone prodrugs that improve calcium regulation and reduce dosing frequency for hypoparathyroidism patients. Parathyroid hormone (PTH) prodrugs are inactive compounds that activate in the body to help maintain calcium and phosphate balance. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical firm, received FDA approval for YORVIPATH (palopegteriparatide), a PTH prodrug for treating chronic hypoparathyroidism in adults. This once-daily treatment offers continuous hormone exposure over 24 hours, providing an alternative to traditional calcium and vitamin D supplements by directly addressing hormone deficiency. The approval of YORVIPATH highlights the growing focus on innovative hormone replacement therapies to improve treatment adherence and clinical outcomes for patients with parathyroid disorders.
In July 2024, AstraZeneca PLC, a UK-based biopharmaceutical company, acquired Amolyt Pharma SAS for $1.05 billion. This acquisition is intended to enhance AstraZeneca's Alexion Rare Disease portfolio by advancing its late-stage pipeline and expanding its bone metabolism franchise with eneboparatide (AZP-3601), a Phase III investigational drug for hypoparathyroidism treatment. Amolyt Pharma SAS is a France-based clinical-stage biotech company specializing in developing novel therapies for rare endocrine diseases, including parathyroid disorders such as hypoparathyroidism.
Major players in the parathyroid disease treatment market are AstraZeneca PLC, Amgen Inc., Teijin Pharma Limited, Kyowa Kirin Co. Ltd., Shandong Buchang Pharmaceuticals Co. Ltd., OPKO Health Inc., Septerna Inc., Entera Bio Ltd., Visen Pharmaceuticals (Shanghai) Co. Ltd., Ascendis Pharma A/S, Aeterna Zentaris Inc., MBX Biosciences Inc., STERIS Healthcare Private Limited, Crinetics Pharmaceuticals Inc., Amorphical Ltd., Vidasym Inc., Extend Biosciences Inc., Rani Therapeutics LLC, Pathalys Pharma Inc., and ProLynx LLC.
Asia-Pacific was the largest region in the parathyroid disease treatment market in 2024. The regions covered in parathyroid disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the parathyroid disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The parathyroid disease treatment market consists of revenues earned by entities by providing services such as diagnostic testing, surgical intervention, hormone level monitoring, post-operative care, and medical management of calcium and phosphate balance. The market value includes the value of related goods sold by the service provider or included within the service offering. The parathyroid disease treatment market also includes sales of lanthanum carbonate, doxercalciferol, calcitriol, lanthanum carbonate, and parsabiv. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Parathyroid Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on parathyroid disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for parathyroid disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The parathyroid disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Calcimimetics; Bisphosphonates; Plicamycin; Hormone Replacement Therapy; Other Treatments
2) By Route Of Administration: Oral; Parenteral
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Calcimimetics: Cinacalcet; Etelcalcetide
2) By Bisphosphonates: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
3) By Plicamycin: Mithramycin (Plicamycin) Monotherapy; Combination Therapies Involving Plicamycin
3. Parathyroid Disease Treatment Market Trends And Strategies
4. Parathyroid Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Parathyroid Disease Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Parathyroid Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Parathyroid Disease Treatment Market Growth Rate Analysis
5.4. Global Parathyroid Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Parathyroid Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Parathyroid Disease Treatment Total Addressable Market (TAM)
6.1. Global Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcimimetics
Bisphosphonates
Plicamycin
Hormone Replacement Therapy
Other Treatments
6.2. Global Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.3. Global Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.4. Global Parathyroid Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Centers
Other End-Users
6.5. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cinacalcet
Etelcalcetide
6.6. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Bisphosphonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alendronate
Ibandronate
Risedronate
Zoledronic Acid
6.7. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Plicamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mithramycin (Plicamycin) Monotherapy
Combination Therapies Involving Plicamycin
6.8. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen Therapy
Progesterone Therapy
Combined Hormonal Therapies
Selective Estrogen Receptor Modulators (SERMs)
6.9. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parathyroid Hormone (PTH) Analogues
Surgery (Parathyroidectomy)
Dietary Supplements
Lifestyle And Nutritional Interventions
7. Parathyroid Disease Treatment Market Regional And Country Analysis
7.1. Global Parathyroid Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Parathyroid Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Parathyroid Disease Treatment Market
9.1. China Parathyroid Disease Treatment Market Overview
9.2. China Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Parathyroid Disease Treatment Market
10.1. India Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Parathyroid Disease Treatment Market
11.1. Japan Parathyroid Disease Treatment Market Overview
11.2. Japan Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Parathyroid Disease Treatment Market
12.1. Australia Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Parathyroid Disease Treatment Market
13.1. Indonesia Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Parathyroid Disease Treatment Market
14.1. South Korea Parathyroid Disease Treatment Market Overview
14.2. South Korea Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Parathyroid Disease Treatment Market
15.1. Western Europe Parathyroid Disease Treatment Market Overview
15.2. Western Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Parathyroid Disease Treatment Market
16.1. UK Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Parathyroid Disease Treatment Market
17.1. Germany Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Parathyroid Disease Treatment Market
18.1. France Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Parathyroid Disease Treatment Market
19.1. Italy Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Parathyroid Disease Treatment Market
20.1. Spain Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Parathyroid Disease Treatment Market
21.1. Eastern Europe Parathyroid Disease Treatment Market Overview
21.2. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Parathyroid Disease Treatment Market
22.1. Russia Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Parathyroid Disease Treatment Market
23.1. North America Parathyroid Disease Treatment Market Overview
23.2. North America Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Parathyroid Disease Treatment Market
24.1. USA Parathyroid Disease Treatment Market Overview
24.2. USA Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Parathyroid Disease Treatment Market
26.1. South America Parathyroid Disease Treatment Market Overview
26.2. South America Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Parathyroid Disease Treatment Market
27.1. Brazil Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Parathyroid Disease Treatment Market
28.1. Middle East Parathyroid Disease Treatment Market Overview
28.2. Middle East Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Parathyroid Disease Treatment Market
29.1. Africa Parathyroid Disease Treatment Market Overview
29.2. Africa Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Parathyroid Disease Treatment Market Competitive Landscape And Company Profiles
